EGFR and glioblastoma: In glioblastoma, the most frequently (~30%) occurring EGFR mutation is EGFRΔIII (EGFR variant III), which results from the in-frame deletion of 801 base pairs spanning exons 2–7 of the coding sequence, resulting in ligand-independent activation of EGFR tyrosine kinase activity [52,53,54].